Imatinib for the treatment of pulmonary arterial hypertension.
Ghofrani
Hossein A
HA
Seeger
Werner
W
Grimminger
Friedrich
F
D001549:Benzamides; D017079:Exercise Tolerance / Q000187:drug effects; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology; D000068877:Imatinib Mesylate; D047908:Intracellular Signaling Peptides and Proteins / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D017479:Receptors, Platelet-Derived Growth Factor / Q000037:antagonists & inhibitors*; D014655:Vascular Resistance / Q000187:drug effects
D001549:Benzamides; D047908:Intracellular Signaling Peptides and Proteins; D010879:Piperazines; D011743:Pyrimidines; C015482:protein kinase modulator; D000068877:Imatinib Mesylate; D017479:Receptors, Platelet-Derived Growth Factor